HUP0201467A3 - A process for the reduction of oxiranyl epothilones to olefinic epothilones - Google Patents
A process for the reduction of oxiranyl epothilones to olefinic epothilonesInfo
- Publication number
- HUP0201467A3 HUP0201467A3 HU0201467A HUP0201467A HUP0201467A3 HU P0201467 A3 HUP0201467 A3 HU P0201467A3 HU 0201467 A HU0201467 A HU 0201467A HU P0201467 A HUP0201467 A HU P0201467A HU P0201467 A3 HUP0201467 A3 HU P0201467A3
- Authority
- HU
- Hungary
- Prior art keywords
- epothilones
- reduction
- oxiranyl
- olefinic
- olefinic epothilones
- Prior art date
Links
- 229930013356 epothilone Natural products 0.000 title 2
- HESCAJZNRMSMJG-KKQRBIROSA-N epothilone A Chemical class C/C([C@@H]1C[C@@H]2O[C@@H]2CCC[C@@H]([C@@H]([C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)O1)O)C)=C\C1=CSC(C)=N1 HESCAJZNRMSMJG-KKQRBIROSA-N 0.000 title 1
- -1 oxiranyl epothilones Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/28—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/316,796 US6320045B1 (en) | 1997-12-04 | 1999-05-21 | Process for the reduction of oxiranyl epothilones to olefinic epothilones |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0201467A2 HUP0201467A2 (en) | 2002-10-28 |
| HUP0201467A3 true HUP0201467A3 (en) | 2005-09-28 |
Family
ID=23230727
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0201467A HUP0201467A3 (en) | 1999-05-21 | 2000-05-15 | A process for the reduction of oxiranyl epothilones to olefinic epothilones |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6320045B1 (hu) |
| EP (1) | EP1178968A4 (hu) |
| JP (1) | JP2003500394A (hu) |
| KR (1) | KR20020005045A (hu) |
| AU (1) | AU4849400A (hu) |
| CA (1) | CA2375029A1 (hu) |
| HK (1) | HK1042294A1 (hu) |
| HU (1) | HUP0201467A3 (hu) |
| IL (1) | IL145178A0 (hu) |
| MX (1) | MXPA01011053A (hu) |
| WO (1) | WO2000071521A1 (hu) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0977563B1 (en) | 1996-12-03 | 2005-10-12 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| US20050043376A1 (en) * | 1996-12-03 | 2005-02-24 | Danishefsky Samuel J. | Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| US6867305B2 (en) | 1996-12-03 | 2005-03-15 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto and analogues thereof |
| US6204388B1 (en) | 1996-12-03 | 2001-03-20 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto and analogues thereof |
| US6780620B1 (en) * | 1998-12-23 | 2004-08-24 | Bristol-Myers Squibb Company | Microbial transformation method for the preparation of an epothilone |
| US6518421B1 (en) | 2000-03-20 | 2003-02-11 | Bristol-Myers Squibb Company | Process for the preparation of epothilone analogs |
| ES2395895T3 (es) * | 2000-09-22 | 2013-02-15 | Helmholtz-Zentrum für Infektionsforschung GmbH | Triazolo-epotilonas |
| US20030004338A1 (en) * | 2001-02-01 | 2003-01-02 | Li Wen Sen | Process for the preparation of epothilone analogs |
| NZ535081A (en) * | 2002-03-08 | 2007-05-31 | Novartis Ag | Combinations comprising epothilone derivatives and alkylating agents |
| ATE452896T1 (de) | 2002-03-12 | 2010-01-15 | Bristol Myers Squibb Co | C3-cyanoepothilonderivate |
| US7244839B2 (en) * | 2002-03-27 | 2007-07-17 | E. I. Du Pont De Nemours And Company | Maize starch containing elevated amounts of actual amylose |
| US6921769B2 (en) | 2002-08-23 | 2005-07-26 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto and analogues thereof |
| US7649006B2 (en) * | 2002-08-23 | 2010-01-19 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto and analogues thereof |
| CN1759115A (zh) | 2002-08-23 | 2006-04-12 | 索隆-基特林癌症研究协会 | 埃坡霉素(epothilone),合成埃坡霉素的中间体,其类似物及其用途 |
| KR101406635B1 (ko) | 2002-09-23 | 2014-06-11 | 브리스톨-마이어스 스큅 컴퍼니 | 에포틸론 ｂ의 제조, 분리 및 정제 방법, 및 에포틸론 ｂ의 ｘ-선 결정 구조 |
| CN1319625C (zh) * | 2003-04-30 | 2007-06-06 | 乐金电子(天津)电器有限公司 | 空气净化器的集尘过滤器 |
| US20050171167A1 (en) * | 2003-11-04 | 2005-08-04 | Haby Thomas A. | Process and formulation containing epothilones and analogs thereof |
| EP1559447A1 (en) | 2004-01-30 | 2005-08-03 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Use of epothilones in the treatment of neuronal connectivity defects such as schizophrenia and autism |
| EP1589011A1 (en) * | 2004-04-22 | 2005-10-26 | Schering Aktiengesellschaft | Novel chiral heptyne derivates for the preparation of epothilones and processes for their preparation |
| EP1674098A1 (en) | 2004-12-23 | 2006-06-28 | Schering Aktiengesellschaft | Stable and tolerable parental formulations of highly reactive organic drug substances with low or no solubility in water |
| EP1930004A1 (en) * | 2006-12-08 | 2008-06-11 | Bayer Schering Pharma Aktiengesellschaft | Use of epothilones in the treatment of osteoporosis and related diseases |
| EP2065054A1 (en) | 2007-11-29 | 2009-06-03 | Bayer Schering Pharma Aktiengesellschaft | Combinations comprising a prostaglandin and uses thereof |
| DE102007059752A1 (de) | 2007-12-10 | 2009-06-18 | Bayer Schering Pharma Aktiengesellschaft | Funktionalisierte, feste Polymernanopartikel enthaltend Epothilone |
| EP2070521A1 (en) | 2007-12-10 | 2009-06-17 | Bayer Schering Pharma Aktiengesellschaft | Surface-modified nanoparticles |
| MX2010011209A (es) | 2008-04-24 | 2010-11-12 | Squibb Bristol Myers Co | Uso de epotilona d en el tratamiento de enfermedades asociadas a tau incluyendo enfermedad de alzheimer. |
| EP2210584A1 (en) | 2009-01-27 | 2010-07-28 | Bayer Schering Pharma Aktiengesellschaft | Stable polymeric composition comprising an epothilone and an amphiphilic block copolymer |
| MX2012013100A (es) | 2010-05-18 | 2013-01-22 | Cerulean Pharma Inc | Composiciones y metodos para el tratamiento de enfermedades autoinmunes y otras enfermedades. |
| CN101906099A (zh) * | 2010-07-16 | 2010-12-08 | 泰州市今朝伟业精细化工有限公司 | 一种埃博霉素d-内酰胺衍生物化学合成方法 |
| US9717803B2 (en) | 2011-12-23 | 2017-08-01 | Innate Pharma | Enzymatic conjugation of polypeptides |
| WO2014009426A2 (en) | 2012-07-13 | 2014-01-16 | Innate Pharma | Screening of conjugated antibodies |
| WO2014072482A1 (en) | 2012-11-09 | 2014-05-15 | Innate Pharma | Recognition tags for tgase-mediated conjugation |
| US10611824B2 (en) | 2013-03-15 | 2020-04-07 | Innate Pharma | Solid phase TGase-mediated conjugation of antibodies |
| US10071169B2 (en) | 2013-06-20 | 2018-09-11 | Innate Pharma | Enzymatic conjugation of polypeptides |
| KR20160042871A (ko) | 2013-06-21 | 2016-04-20 | 이나뜨 파르마, 에스.아. | 폴리펩티드의 효소적 콘쥬게이션 |
| CN103936748A (zh) * | 2014-05-08 | 2014-07-23 | 成都摩尔生物医药有限公司 | 一种埃博霉素b内酰胺衍生物的制备方法 |
| WO2019092148A1 (en) | 2017-11-10 | 2019-05-16 | Innate Pharma | Antibodies with functionalized glutamine residues |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4138042C2 (de) | 1991-11-19 | 1993-10-14 | Biotechnolog Forschung Gmbh | Epothilone, deren Herstellungsverfahren sowie diese Verbindungen enthaltende Mittel |
| DE59609305D1 (de) | 1995-11-17 | 2002-07-11 | Biotechnolog Forschung Gmbh | Epothilon-Derivate und deren Herstellung |
| DE19542986A1 (de) | 1995-11-17 | 1997-05-22 | Biotechnolog Forschung Gmbh | Epothilon-Derivate und deren Verwendung |
| DE19639456A1 (de) | 1996-09-25 | 1998-03-26 | Biotechnolog Forschung Gmbh | Epothilon-Derivate, Herstellung und Mittel |
| DE19645361A1 (de) | 1996-08-30 | 1998-04-30 | Ciba Geigy Ag | Zwischenprodukte innerhalb der Totalsynthese von Epothilon A und B, Teil II |
| JP2001500851A (ja) | 1996-08-30 | 2001-01-23 | ノバルティス アクチエンゲゼルシャフト | エポシロンの製造法および製造過程中に得られる中間生産物 |
| DE19645362A1 (de) | 1996-10-28 | 1998-04-30 | Ciba Geigy Ag | Verfahren zur Herstellung von Epothilon A und B und Derivaten |
| PT941227E (pt) | 1996-11-18 | 2004-08-31 | Biotechnolog Forschung Mbh Gbf | Epothilona d sua preparacao e sua utilizacao como agente citostatico ou como agente de proteccao fitossanitaria |
| US6515016B2 (en) | 1996-12-02 | 2003-02-04 | Angiotech Pharmaceuticals, Inc. | Composition and methods of paclitaxel for treating psoriasis |
| EP0977563B1 (en) | 1996-12-03 | 2005-10-12 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| US6441186B1 (en) | 1996-12-13 | 2002-08-27 | The Scripps Research Institute | Epothilone analogs |
| DE19701758A1 (de) | 1997-01-20 | 1998-07-23 | Wessjohann Ludgar A Dr | Epothilone-Synthesebausteine |
| EP1201666A3 (de) | 1997-02-25 | 2003-03-05 | Gesellschaft für biotechnologische Forschung mbH (GBF) | Seitenkettenmodifizierte Epothilone |
| DE19713970B4 (de) | 1997-04-04 | 2006-08-31 | R&D-Biopharmaceuticals Gmbh | Epothilone-Synthesebausteine II - Prenylderivate |
| JP4065573B2 (ja) | 1997-04-18 | 2008-03-26 | ベーリンガー・インゲルハイム・インテルナツィオナール・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 反応媒体として圧縮二酸化炭素中における二官能性または多官能性基質の選択的オレフィンメタセシス |
| DE19821954A1 (de) | 1997-05-15 | 1998-11-19 | Biotechnolog Forschung Gmbh | Verfahren zur Herstellung eines Epothilon-Derivats |
| DE19720312A1 (de) | 1997-05-15 | 1998-11-19 | Hoechst Ag | Zubereitung mit erhöhter in vivo Verträglichkeit |
| DE19726627A1 (de) | 1997-06-17 | 1998-12-24 | Schering Ag | Zwischenprodukte, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Epothilon |
| AU8542898A (en) | 1997-07-16 | 1999-02-10 | Schering Aktiengesellschaft | Thiazole derivatives, method for their production and use |
| DK1005465T3 (da) | 1997-08-09 | 2007-11-05 | Bayer Schering Pharma Ag | Nye epothilon-derivater, fremgangsmåde til fremstilling heraf og deres farmaceutiske anvendelse |
| TWI221469B (en) * | 1997-12-04 | 2004-10-01 | Bristol Myers Squibb Co | A process for the reduction of oxiranyl epothilones to olefinic epothilones |
-
1999
- 1999-05-21 US US09/316,796 patent/US6320045B1/en not_active Expired - Lifetime
-
2000
- 2000-05-15 EP EP00930725A patent/EP1178968A4/en not_active Withdrawn
- 2000-05-15 HU HU0201467A patent/HUP0201467A3/hu unknown
- 2000-05-15 AU AU48494/00A patent/AU4849400A/en not_active Abandoned
- 2000-05-15 KR KR1020017014811A patent/KR20020005045A/ko not_active Application Discontinuation
- 2000-05-15 MX MXPA01011053A patent/MXPA01011053A/es not_active Application Discontinuation
- 2000-05-15 IL IL14517800A patent/IL145178A0/xx unknown
- 2000-05-15 WO PCT/US2000/013253 patent/WO2000071521A1/en not_active Application Discontinuation
- 2000-05-15 CA CA002375029A patent/CA2375029A1/en not_active Abandoned
- 2000-05-15 JP JP2000619778A patent/JP2003500394A/ja active Pending
-
2002
- 2002-04-30 HK HK02103239.3A patent/HK1042294A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA01011053A (es) | 2002-07-22 |
| IL145178A0 (en) | 2002-06-30 |
| KR20020005045A (ko) | 2002-01-16 |
| HK1042294A1 (zh) | 2002-08-09 |
| CA2375029A1 (en) | 2000-11-30 |
| JP2003500394A (ja) | 2003-01-07 |
| EP1178968A1 (en) | 2002-02-13 |
| WO2000071521A1 (en) | 2000-11-30 |
| EP1178968A4 (en) | 2002-06-19 |
| HUP0201467A2 (en) | 2002-10-28 |
| US6320045B1 (en) | 2001-11-20 |
| AU4849400A (en) | 2000-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0201467A3 (en) | A process for the reduction of oxiranyl epothilones to olefinic epothilones | |
| HUP0100582A3 (en) | A process for the reduction of oxiranyl epothilones to olefinic epothilones | |
| HUP0300693A3 (en) | A process for the preparation of epothilone analogs and intermediates | |
| PL363800A1 (en) | A process for the manufacture of surface elements | |
| EG22541A (en) | Process for the production of olefins | |
| HUP0000283A3 (en) | New process for the production of quetiapine | |
| AU2002240014A1 (en) | A process for the preparation of epothilone analogs | |
| HUP0200583A3 (en) | A process for the preparation of aziridinyl epothilones from oxiranyl epothilones | |
| AU5558800A (en) | Process for the production of 2-(2-pyridinylmethylsulphinyl)-1h-benzimidazoles | |
| GB9905422D0 (en) | Process for the production of olefins | |
| HK1048112B (zh) | 3-乙烯基-頭孢化合物的製備方法 | |
| IL154464A0 (en) | Catalytic process for the preparation of thiazole derivatives | |
| HK1045498B (zh) | 純化雙醋瑞因的方法 | |
| HK1052350A1 (zh) | 一種合成嗎啉基苯類化合物的新方法 | |
| HUP0400485A3 (en) | Process for the preparation of 5-phenylpentanoyl-ala-arginyl-{2-[3-amino-2-oxopyrrolidin-1-yl]propionyl}-alanyl-arginyl-alanyl-4-aminophenylacetamide | |
| GB2327420B (en) | Process for the production of oxygenated compounds | |
| HUP0104259A2 (en) | A process for the synthesis of ritonavir | |
| GC0000365A (en) | Process for the production of olefins | |
| GB0013916D0 (en) | Process for the surface treatment of a connecting rod | |
| GB0007561D0 (en) | A process for the production of a fat | |
| IL149713A0 (en) | Process for the production of trifluormethylacetophenones | |
| AU2001272424A1 (en) | A process for the purification of diacerein | |
| HUP0201574A3 (en) | Process for the preparation of fumagillin | |
| PL350138A1 (en) | Novel process of preparing a benzothiazolone compound | |
| HUP0200585A3 (en) | A process for the preparation of thiazolidine derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |